Dapagliflozin and Empagliflozin Shows Comparable Effectiveness in Type 2 Diabetes: Study Jacinthlyn Sylvia10 Sept 2025 9:00 AM ISTA new study published in the journal of Diabetes Research and Clinical Practice found that dapagliflozin and empagliflozin commonly used SGLT2...
NPPA Fixes Retail Prices of 42 Formulations Including Amoxycillin, Dapagliflozin, Cefixime Susmita Roy3 Sept 2025 10:11 AM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers, has...
CDSCO Panel Allows Ravenbhel to Conduct BE, Phase III Trial of Dapagliflozin, Sacubitril, Valsartan FDC Susmita Roy1 Sept 2025 1:52 PM ISTNew Delhi: Ravenbhel Healthcare has got the go-ahead from the Subject Expert Committee (SEC), functional under the Central Drugs Standard Control...
Sun Pharma's Dapagliflozin, Glimepiride, Metformin FDC Fails to Secure CDSCO Panel Nod Over Safety, Utility Concerns Susmita Roy19 Aug 2025 3:11 PM ISTNew Delhi: Expressing doubts over the clinical utility of administering such a small dose of Glimepiride once daily, especially considering over the...
Submit BE Raw Data, Interaction Study on Dapagliflozin-Rosuvastatin FDC: Expert Panel Tells Pure and Cure Susmita Roy19 Aug 2025 3:02 PM ISTNew Delhi: In line with the proposal presented by Pure and Cure Healthcare for the Dapagliflozin plus Rosuvastatin film-coated tablet, the Subject...
Dapagliflozin Improves Heart Structure in HFpEF Patients with Type 2 Diabetes:Study Jacinthlyn Sylvia7 Aug 2025 9:30 AM ISTA new study published in the European Journal of Medical Research revealed that dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2)...
Dapagliflozin Reduces Heart Failure Risk After TAVI: Key Findings from the DapaTAVI Trial Deeksha Bhandari6 Aug 2025 8:30 AM ISTDapagliflozin significantly reduced the risk of all-cause mortality or worsening heart failure by 28% in high-risk patients undergoing transcatheter...
Dapagliflozin reduced mortality risk in aortic stenosis patients undergoing TAVI: Study Jacinthlyn Sylvia2 Aug 2025 8:45 AM ISTA new study published in The New England Journal of Medicine showed that daily dapagliflozin dramatically reduced the risk of death or deteriorating...
Uncontrolled T2D in India: Valuable Consideration for Dapagliflozin Sitagliptin Combination Dr. D.C. Sharma25 July 2025 12:11 PM ISTIndia accounts for 1 in 7 adults living with diabetes globally. An estimated 89.8 million adults aged 20-79 years in India are living with diabetes,...
Eris Gets CDSCO Panel Nod To Dapagliflozin-Bisoprolol-Sacubitril Valsartan Combo Kit, Phase IV Trial Mandated Parthika Patel23 July 2025 7:41 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Cardiovascular division of the Central Drugs Standard Control Organisation (CDSCO) has...
Dapagliflozin Shines in Post-TAVI Patients:DAPA-TAVI Trial Findings Prem Aggarwal2 July 2025 11:01 AM ISTDapagliflozin reduced the risk of all-cause mortality or worsening heart failure by 28% in patients with aortic stenosis undergoing transcatheter...
State Drug Alert: CDSCO Flags 128 Batches Including Paracetamol, Dapagliflozin Farhat Nasim22 Jun 2025 3:00 PM ISTNew Delhi: As part of its ongoing quality surveillance efforts, the Central Drugs Standard Control Organisation (CDSCO) has flagged more than 120...
